Pinatuzumab Vedotin Uses, Dosage, Side Effects and more
Pinatuzumab Vedotin is under investigation in clinical trial NCT01691898 (A Study of Pinatuzumab Vedotin (DCDT2980S) Combined With Rituximab or Polatuzumab Vedotin (DCDS4501A) Combined With Rituximab or Obinutuzumab in Participants With Relapsed or Refractory B-Cell Non-Hodgkin's Lymphoma (NHL)).
| Trade Name | Pinatuzumab Vedotin |
| Generic | Pinatuzumab vedotin |
| Pinatuzumab vedotin Other Names | DCDT2980S, Pinatuzumab vedotin |
| Type | |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | January 7, 2025 at 1:49 am |
